Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    22503032 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Capecitabine in the Perioperative Treatment of Rectal Cancer
Condition: Rectal Cancer
Interventions: Drug: Capecitabine;   Drug: 5-FU
2 Enrolling by invitation Low-dose Capecitabine Adjuvant Chemotherapy for Elderly Patients With Stage II/III Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Drug: Capecitabine

Indicates status has not been verified in more than two years